关键词：青光眼；医疗器械；增长前景；治疗市场；市场规模
摘 要：This report covers the present scenario and the growth prospects of the Global Glaucoma Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various ophthalmic solutions used in the treatment of glaucoma. The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Glaucoma Therapeutics market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Glaucoma Therapeutics Market in the US

06.3.1 Market Size and Forecast

06.4 Glaucoma Therapeutics Market in Europe

06.4.1 Market Size and Forecast

06.5 Glaucoma Therapeutics Market in Japan

06.5.1 Market Size and Forecast

06.6 Five Forces Analysis

07. Pipeline Snapshot

08. Rate of Incidence and Prevalence

08.1.1 US

08.1.2 UK

08.1.3 Spain

08.1.4 Germany

08.1.5 Japan

09. Market Segmentation by Drug Class

10. Geographical Segmentation

10.1 Glaucoma Therapeutics Market in the Americas

10.1.1 Market Size and Forecast

10.2 Glaucoma Therapeutics Market in the EMEA

Region

10.2.1 Market Size and Forecast

10.3 Glaucoma Therapeutics Market in the APAC

Region

10.3.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Allergen Inc.

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 SWOT Analysis

19.2 Merck & Co. Inc.

19.2.1 Business Overview

19.2.2 Business Segmentation

19.2.3 Key Information

19.2.4 SWOT Analysis

19.3 Novartis AG

19.3.1 Business Overview

19.3.2 Business Segmentation

19.3.3 Key Information

19.3.4 SWOT Analysis

19.4 Pfizer Inc.

19.4.1 Business Overview

19.4.2 Business Segmentation

19.4.3 Key Information

19.4.4 SWOT Analysis

20. Other Reports in this Series